Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Jun 10;8(10):1030–1040. doi: 10.1002/sctm.19-0004

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 The Authors. stem cells translational medicine published by Wiley Periodicals, Inc. on behalf of AlphaMed Press

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

HGF alone is sufficient to prolong graft survival. (A): Schematic of experimental design. After transplantation, grafts were treated with HGF eye drops (0.1%) or control eye drops twice daily for 2 weeks. Slit‐lamp microscopy was used to evaluate the corneal opacity of naïve, control‐treated, and HGF‐treated mice. (B): Kaplan‐Meier analysis showing graft survival of HGF‐treated allogeneic graft recipients, control‐treated allogeneic graft recipients, untreated allogeneic graft recipients, and untreated syngeneic graft recipients (n = 8–10 in each group; log‐rank test; p = .022). Abbreviation: HGF, hepatocyte growth factor.